Lion Head Co., Ltd. announced that in the first half of 2026, it achieved operating income of 243 million yuan, an increase of 6.98%; net profit attributable to shareholders of listed companies was 663,500 yuan, an increase of 18.03%; and net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was -81,700 yuan. The board of directors of the company did not propose a plan to distribute profits or increase share capital from the Provident Fund. The transaction where the company plans to issue shares and pay cash to purchase 97.4399% of Hangzhou Lipo Technology Co., Ltd. and raise supporting capital has been reviewed by the Shanghai Stock Exchange M&A and restructuring committee, and registration is required before it can be implemented.

Lion Head Co., Ltd. announced that in the first half of 2026, it achieved operating income of 243 million yuan, an increase of 6.98%; net profit attributable to shareholders of listed companies was 663,500 yuan, an increase of 18.03%; and net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was -81,700 yuan. The board of directors of the company did not propose a plan to distribute profits or increase share capital from the Provident Fund. The transaction where the company plans to issue shares and pay cash to purchase 97.4399% of Hangzhou Lipo Technology Co., Ltd. and raise supporting capital has been reviewed by the Shanghai Stock Exchange M&A and restructuring committee, and registration is required before it can be implemented.